The objectives of this study were to determine the amplitude of movement differences and asymmetries between feet during the stance phase and to evaluate the effects of foot orthoses (FOs) on foot kinematics in the stance phase during running. In total, 40 males were recruited (age: 43.0 ± 13.8 years, weight: 72.0 ± 5.5 kg, height: 175.5 ± 7.0 cm). Participants ran on a running treadmill at 2.5 m/s using their own footwear, with and without the FOs. Two inertial sensors fixed on the instep of each of the participant’s footwear were used. Amplitude of movement along each axis, contact time and number of steps were considered in the analysis. The results indicate that the movement in the sagittal plane is symmetric, but that it is not in the frontal and transverse planes. The right foot displayed more degrees of movement amplitude than the left foot although these differences are only significant in the abduction case. When FOs are used, a decrease in amplitude of movement in the three axes is observed, except for the dorsi-plantar flexion in the left foot and both feet combined. The contact time and the total step time show a significant increase when FOs are used, but the number of steps is not altered, suggesting that FOs do not interfere in running technique. The reduction in the amplitude of movement would indicate that FOs could be used as a preventive tool. The FOs do not influence the asymmetry of the amplitude of movement observed between feet, and this risk factor is maintained. IMU devices are useful tools to detect risk factors related to running injuries. With its use, even more personalized FOs could be manufactured.
There is some uncertainty regarding how foot orthoses (FO) affect the biomechanics of the lower extremities during running in non-injured individuals. This study aims to describe the behavior of the angular velocity of the foot in the stride cycle measured with a low-sampling-rate IMU device commonly used by podiatrists. Specific objectives were to determine if there are differences in angular velocity between the right and left foot and to determine the effect of foot orthoses (FO) on the 3D angular velocity of the foot during running. The sample was composed of 40 male adults (age: 43.0 ± 13.8 years, weight: 72.0 ± 5.5 kg, and height: 175.5 ± 7.0 cm), who were healthy and without any locomotor system alterations at the time of the test. All subjects use FO on a regular basis. The results show that there are significant differences in the transverse plane between feet, with greater differences in the right foot. Significant differences between FO and non-FO conditions were observed in the frontal and transverse planes on the left foot and in the sagittal and transverse planes on the right foot. FO decreases the velocity of the foot in dorsi-plantar flexion and abduction and increases the velocity in inversion. The kinematic changes in foot velocity occur between 30% and 60% of the complete cycle, and the FO reduces the velocity in abduction and dorsi–plantar flexion and increases the velocity in inversion–eversion, which facilitates the transition to the oscillating leg and with it the displacement of the center of mass. Quantifying possible asymmetries and assessing the effect of foot orthoses may aid in improving running mechanics and preventing injuries in individuals.
Introduction: Running is a popular and accessible activity with well-established health benefits, although it carries a risk of musculoskeletal injuries. Biomechanical analysis helps identify risk factors and guide preventive strategies. Inertial measurement units (IMUs) have enhanced the assessment of running technique. Objective: This study aimed to review the methodological protocols applied in the kinematic analysis of treadmill running among recreational runners using IMUs in healthy individuals. Methodology: The review followed PRISMA-ScR guidelines. Searches were conducted in Medline/PubMed, Web of Science, SportDiscus, and SafeJournal. Eligible studies included descriptive, reliability, validity, and intervention designs using IMUs in healthy participants. Methodological quality was assessed with the modified Downs & Black Index, and inter-rater reliability with Cohen’s Kappa coefficient. Results: From 6,169 records, 30 studies met the eligibility criteria. A total of 31 devices were analyzed, with sampling frequencies ranging from 1600 Hz to 1 Hz. The tibia was the most common sensor location. Across studies, 553 men (66.2%) and 282 women (33.8%) participated. The most frequently assessed parameters were acceleration, angular velocity, and spatiotemporal variables such as cadence and contact time. Conclusions: Treadmill-based IMUs are valid tools for measuring kinematic parameters and provide valuable insights into running technique and performance. Measurement accuracy depends on sensor placement. Key limitations included the low representation of women, the predominance of recreational runners, and the frequent use of reduced running speeds. Future studies should incorporate balanced sex representation and systematic comparisons of sensor locations to enhance reproducibility and support injury-prevention programs.
15 July 2025 in Journal of Bodywork and Movement Therapies
Core stability is maintained mainly by abdominal and lumbar function, including the diaphragm muscle, connecting trunk's muscle activity and lower limbs movement. However, the diaphragm training is not frequently included in core training sessions, especially in sports injury prevention and treatment. The aim of the study is designing and validating a protocol of rib cage mobility, using the Delphi Method. A clinical practice protocol was designed based on breathing exercise and diaphragm and ribs manual therapy, twice a week for eight weeks. Delphi Method was used to validate the protocol by a committee of eight experts on manual therapy and breathing rehabilitation, who rated the exercises. Then, the coefficient of variation of the answers was calculated, and the questionnaire repeated until the consensus was reached. In the second round of questions, the 87,5 % (n = 7) of the experts were "Totally agree" in 4 out of the 5 exercises described. Consensus was determined as the coefficient of variation of the answers decreased after two rounds, and the validation was concluded. The clinical protocol of breathing exercises and manual therapy of the ribs and muscle diaphragm has been designed and later successfully validated using the Delphi method.
Study aim: To analyze the effect of 6 mg/kg of caffeine (CAFF) on performance and technique. Material and methods: In a randomized, crossover, double-blind study, 14 trained naïve-low consumers of CAFF executed 6 back squats, both unfatigued and fatigued, in a control, a placebo (PLA), and a CAFF session at the same setting, with a 7-day wash-out. Computer-generated random numbers allocated participants to intervention sequences. The primary outcomes were performance and biomechanical parameters. Results: The analyses considered the seven participants randomized per sequence. Hip flexion at the bottom position in PLA ( d = 0.72), and its eccentric ( d = 0.94–1.32) and concentric ( d = 0.68–1.01) range of motion (ROM) in PLA and CAFF, increased, while fatigue augmented it at the final position ( d = 0.47), and decreased its eccentric ( d = 0.60) and concentric ( d = 0.84) ROM. Fatigue decreased knee flexion at the bottom position ( d = 0.21) and concentric ROM ( d = 0.94) but augmented it at the final position ( d = 0.53), and PLA increased its eccentric ROM ( d = 0.79). CAFF and PLA reduced ankle dorsiflexion at the bottom ( d = 0.85–0.89) and final ( d = 0.78–0.86) positions. PLA worsened concentric time ( d = 1.07), peak vertical force (PVF) ( d = 0.74), and rate of force development (RFD) ( d = 0.88). Fatigue reduced eccentric ( d = 0.57) and concentric ( d = 0.70) PVF, concentric RFD ( d = 0.47), and mean propulsive bar velocity ( d = 0.66). Most of CAFF common side effects were reported. Conclusion: CAFF was not ergogenic for squats, while PLA hindered performance. CAFF, PLA, and fatigue modified the squat technique, potentially affecting its benefits. This trial was supported by “AGAUR-FI ajuts Joan Oró” and prospectively registered on ClinicalTrials.gov (NCT06039358).